We found that Mpzl3 ASO treatment improved glucose tolerance in HED mice similar to the phenotype of global Mpzl3 KO mice (Figure 3; Czyzyk et al., 2013). This evidence concerns the gene MPZL3 and hypohidrotic ectodermal dysplasia.